<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Optometry Product Guide &#187; CE mark</title>
	<atom:link href="http://www.optometryproductguide.com/blog/tag/ce-mark/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.optometryproductguide.com/blog</link>
	<description>A comprehensive guide to optometry products for medical professionals</description>
	<lastBuildDate>Fri, 11 Jun 2010 13:00:25 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Ocutec Granted CE Mark Approval for its PEG Hydrogel-Based Contact Lens</title>
		<link>http://www.optometryproductguide.com/blog/2009/11/26/ocutec-granted-ce-mark-approval-for-its-peg-hydrogel-based-contact-lens/</link>
		<comments>http://www.optometryproductguide.com/blog/2009/11/26/ocutec-granted-ce-mark-approval-for-its-peg-hydrogel-based-contact-lens/#comments</comments>
		<pubDate>Thu, 26 Nov 2009 15:21:09 +0000</pubDate>
		<dc:creator>Jim Marino</dc:creator>
				<category><![CDATA[Contact Lens]]></category>
		<category><![CDATA[American Academy of Optometry]]></category>
		<category><![CDATA[CE mark]]></category>
		<category><![CDATA[hydrogel based lenses]]></category>
		<category><![CDATA[Ocutec Ltd]]></category>

		<guid isPermaLink="false">http://www.optometryproductguide.com/blog/?p=159</guid>
		<description><![CDATA[Ocutec Ltd, the has announced at the American Academy of Optometry Meeting in Orlando CE Mark approval for its first poly(ethylene) glycol (PEG) hydrogel-based contact lens product. In initial patient acceptance trials, this next generation of lenses has demonstrated superior oxygen permeability compared to existing hydrogel based lenses. It is anticipated that the lenses will [...]]]></description>
			<content:encoded><![CDATA[<p><a href="http://www.optometryproductguide.com/blog/wp-content/uploads/2009/11/Ocutec-Ltd.png"><img class="alignleft size-full wp-image-160" style="margin: 5px" src="http://www.optometryproductguide.com/blog/wp-content/uploads/2009/11/Ocutec-Ltd.png" border="0" alt="Ocutec Ltd" width="200" height="53" /></a>Ocutec Ltd, the has announced at the American Academy of Optometry Meeting in Orlando CE Mark approval for its first poly(ethylene) glycol (PEG) hydrogel-based contact lens product. In initial patient acceptance trials, this next generation of lenses has demonstrated superior oxygen permeability compared to existing hydrogel based lenses. It is anticipated that the lenses will provide similar health benefits to silicone hydrogels without the drawbacks of incorporating hydrophobic silicone into the lens polymer.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.optometryproductguide.com/blog/2009/11/26/ocutec-granted-ce-mark-approval-for-its-peg-hydrogel-based-contact-lens/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>NeoVista Launches VIDION® ANV® Therapy System</title>
		<link>http://www.optometryproductguide.com/blog/2009/11/19/neovista-launches-vidion%c2%ae-anv%c2%ae-therapy-system/</link>
		<comments>http://www.optometryproductguide.com/blog/2009/11/19/neovista-launches-vidion%c2%ae-anv%c2%ae-therapy-system/#comments</comments>
		<pubDate>Thu, 19 Nov 2009 14:45:47 +0000</pubDate>
		<dc:creator>Jim Marino</dc:creator>
				<category><![CDATA[Vision therapy]]></category>
		<category><![CDATA[age-related macular degeneration]]></category>
		<category><![CDATA[blindness]]></category>
		<category><![CDATA[CE mark]]></category>
		<category><![CDATA[NeoVista Inc.]]></category>
		<category><![CDATA[VIDION® Anti NeoVascular (ANV®) Therapy System]]></category>

		<guid isPermaLink="false">http://www.optometryproductguide.com/blog/?p=155</guid>
		<description><![CDATA[NeoVista, Inc. has announced that the company’s revolutionary new surgical device is now available in the UK and offers fresh hope to 250,000 patients with wet age-related macular degeneration (AMD) –- a debilitating and aggressive eye condition that can lead to blindness within 3 months if left untreated. The VIDION® Anti NeoVascular (ANV®) Therapy System [...]]]></description>
			<content:encoded><![CDATA[<p><a href="http://www.optometryproductguide.com/blog/wp-content/uploads/2009/11/NeoVista.png"><img class="alignright size-full wp-image-156" style="margin: 5px" src="http://www.optometryproductguide.com/blog/wp-content/uploads/2009/11/NeoVista.png" border="0" alt="NeoVista" width="200" height="113" /></a>NeoVista, Inc. has announced that the company’s revolutionary new surgical device is now available in the UK and offers fresh hope to 250,000 patients with wet age-related macular degeneration (AMD) –- a debilitating and aggressive eye condition that can lead to blindness within 3 months if left untreated. The VIDION® Anti NeoVascular (ANV®) Therapy System has recently received a CE mark certifying that it has met the EU’s Medical Device Directive.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.optometryproductguide.com/blog/2009/11/19/neovista-launches-vidion%c2%ae-anv%c2%ae-therapy-system/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
